Correlation between serum lipoprotein(a) and angiographic coronary artery disease in non-insulin-dependent diabetes mellitus

Journal of Internal Medicine

Volumn 242, Issue 6, 1997, Pages 449-454

  Comlekci A ^a   Biberoglu, S ^a   Kozan, O ^a   Bahceci O ^a   Ergene, O ^a   Nazli, C ^a   Kinay, O ^a   Guner G ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Coronary artery disease; Coronory angiography; Lipoprotein(a); NIDDM

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HEART CATHETERIZATION; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0031456747     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2796.1997.tb00017.x     Document Type: Article

References (38)

1. Aro A. Macroangiopathy in type II diabetes. Acta Endocrinol 1984; 262: 75-8.
2. Kannel W, McGee D. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham Study. Diabetes Care 1979; 2: 120-26.
3. Kannel W, McGee D. Diabetes and cardiovascular disease: the Framingham Study. JAMA 1979; 241: 2035-8.
4. Gaubatz J, Heideman C, Gotto AJ, Morisett J, Dahlen G. Human plasma lipoprotein (a). Structural properties. J Biol Chem 1983; 258: 4582-9.
5. Berg K. A new serum type system in man - the Lp system. Acta Pathol Microbiol Scand 1963; 59: 369-82.
6. Dahlen G, Ericson C, Furberg C, Lundvist L, Svardsudd K, Angina of effort and an extra pre-beta lipoprotein fraction. Acta Medica Scand 1972; 531: 11-15.
7. Dahlen G, Berg K, Gilnas T, Ericson C. Lp (a) liporotein/prebetal-lipoprotein in Swedish middle-aged males and in patients with coronary heart disease. Clin Genet 1975; 7: 334-41.
8. Rhoads GG, Dahlen G, Berg K, Morton NE, Dannenberg AL, Lp (a) lipoprotein as a risk factor for myocardial infarction. JAMA 1986; 256: 2540-44.
9. Sandkamp M, Funke H, Schulte H, Kohler E, Assman G. Lipoprotein (a) is an independent risk factor for myocardial infarction at a young age. Clin Chem 1990; 36: 20-23.
10. Utermann G. The mysteries of Lipoprotein (a). Science 1989; 246: 904-10.
11. Schaefer EJ, Lamon-Fava S, Jenner JL, McNamara JR, Ordovas JM, Davis CE, et al. Lipoprotein (a) levels and risk of coronary heart disease in men. The lipid research clinics coronary primary prevention trial. JAMA 1994; 271: 999-1003.
12. Genest JJ, Jenner J, McNamara J, Ordovas JM, Silberman SR, Wilson PW, et al. Prevalance of lipoprotein (a) [Lp (a) ] excess in coronary artery disease. Am J Cardiol 1991; 67: 1039-45.
13. Scanu AM, Lawn RM, Berg K, Lipoprotein (a) and atherosclerosis. Ann Intern Med 1991; 115: 209-18.
14. Edelberg J. Pizzo S. Why is lipoprotein (a) relevant to thrombosis? Am J Clin Nutr 1992; 56: 791S-2S.
15. Rath M, Niendorf A, Reblin T, Dietel M, Krebber H, Beisiegel U, Detection and quantification of lipoprotein (a) in the arterial wall of 107 coronary bypass patients. Arteriosclerosis 1989; 9: 579-92.
16. Cushing GL, Gaubatz JW, Nava ML, Burdick BJ, Boran TMA, Guyton JR, et al. Quantification and localization of apolipoprotein (a) and B in coronary artery bypass vein grafts resected at re-operation. Arteriosclerosis 1989; 9: 593-603.
17. Bruckert E, Davidoff P, Grimaldi A, Truffert J, Giral P. Doumith R, et al. Increased serum levels of lipoprotein (a) in diabetes mellitus and their reduction with glycemic control JAMA 1990; 263: 35-6 (letter).
18. Jenkins A, Steele J, Janus E, Best J, Increased plasma apolipoprotein (a) levels in IDDM patients with microalbuminuria. Diabetes 1991; 40: 787-90.
19. Haffner SM, Tuttle KR, Rainwater DL. Decrease of lipoprotein (a) with improved glycemic control in IDDM subjects. Diabetes Care 1991; 14: 302-7.
20. O'Brien T, Nguyen T, Harrison J, Bailey K, Dyck P, Kottke B. Lipids and Lp (a) lipoprotein levels and coronary artery disease in subjects with non-insulin-dependent diabetes mellitus. Mayo Clin Proc 1994; 69: 430-35.
21. Jenkins A, Steele J, Junus E, Santamaria J, Best J, Plasma apolipoprotein (a) is increased in type II (non-insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 1992; 35: 1055-9.
22. Haffner SM, Morales PA, Stern MP, Gruber K. Lp (a) concentrations in NIDDM. Diabetes 1992; 41: 1267-72.
23. Rainwater D. MacCluer JW. Stern M, VandeBerg JL. Haffner S. Effects of NIDDM on lipoprotein (a) concentration and apolipoprotein (a) size. Diabetes 1994; 43: 942-6.
24. Csazar A, Dieplinger H, Sandholzer C, Karadi I, Juhasz E. Drexel H, et al. Plasma lipoprotein (a) concentration and phenotypes in diabetes mellitus. Diabetologia 1993; 36: 47-51.
25. Velho G, Erlich D, Tuppin E, Neel D, Cohen D, Froguel P, et al. Lipoprotein (a) in diabetic patients and normoglycemic relatives in familial NIDDM. Diabetes Care 1993; 16: 742-7.
26. Joven J, Vilella E, Serum levels of lipoprotein (a) in patients with well controlled non-insulin diabetes mellitus. JAMA 1991; 265: 1113-4 (letter).
27. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intotelance. Diabetes 1979; 28: 1039-57.
28. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifugation. Clin Chem 1972; 18: 499-502.
29. Watts GF, Lewis B, Brunt JNH, Lewis ES, Coltart DJ, Smith LDR, et al. Effects on coronary artery disease of lipidlowering diet, or diet plus cholestyramine, in the St Thomas Atherosclerosis Regression Study (STARS). Lancet 1992; 339: 563-9.
30. Austen WG, Edward JE, Frye RI, Gensini GG, Gott VL, Griffith LS, et al. AHA committee report. A reporting system on patients evaluated for coronary artery disease. Circulation 1975; 51: 7-40.
31. Ryan T, Faxon D, Gunnar R. A report of the ACC/AHA task force on assesment of diagnostic and therapeutic cardiovascular procedures. J Am Coll Cardiol 1988; 12: 529-38.
32. Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM. Association of levels of lipoprotein Lp (a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986; 74: 758-65.
33. Ritter M, Richter W, Lyko K, Schwanelt P. Lp (a) serum concentrations and metabolic control. Diabetes Care 1992; 15: 1441-2 (letter).
34. Haffner S, Tuttle K, Rainwater D. Preliminary report: lack of change of Lp (a) concentrations with improved glycemic control in subjects with type II diabetes. Metabolism 1992; 41: 116-20.
35. Haffner S, Moss S, Klein B, Klein R. Lack of association between Lp (a) concentrations and coronary heart disease mortality in diabetes: the Wisconsin Epidemiologic Survey of Diabetic Retinopathy. Metabolism 1992; 41: 194-7.
36. Watts GF, Gwilym RM, Mazurkiewicz J, Coltart J. Independent correlation between plasma lipoprotein (a) and angiographic coronary artery disease in NIDDM. Diabetes Care 1995; 18: 234-6.
37. Armstrong V, Cremer P, Eberle E, Manke A, Schulze F, Wieland H, et al. The association between serum Lp (a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. Atherosclerosis 1986; 62: 249-57.
38. Nissen SE, De Frarco AC, Raymond RE, Franco S. Angiographically unrecognized disease at 'normal' reference sites: a risk factor for suboptimal results after coronary interventions. Circulation 1993; 88:412A.